We are live on ! Find out more
CBIO

Crescent Biopharma
CBIO

63 hedge funds and large institutions have $477M invested in Crescent Biopharma in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 8

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

67% more capital invested

Capital invested by funds: $286M → $477M (+$191M)

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

9% more funds holding

Funds holding: 58 → 63 (+5)

79.42% less ownership

Funds ownership: 173.59% → 94.17% (-79%)

Holders
63
Holders Change
+5
Holders Change %
+8.62%
% of All Funds
0.78%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
17
Increased
18
Reduced
8
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$16.1M
2
TCM
Tang Capital Management
California
+$3.3M
3
Millennium Management
Millennium Management
New York
+$3M
4
Goldman Sachs
Goldman Sachs
New York
+$2.33M
5
Marshall Wace
Marshall Wace
United Kingdom
+$2.05M

Top Sellers

1
ACM
ADAR1 Capital Management
Texas
-$6.38M
2
DCM
Driehaus Capital Management
Illinois
-$3.59M
3
HCM
Heights Capital Management
California
-$3.13M
4
PA
Perceptive Advisors
New York
-$2.83M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$75.9M – – –
BI
2
BVF Inc
California
$50.5M – – –
FFM
3
Fairmount Funds Management
Pennsylvania
$50.5M – – –
VA
4
VR Adviser
New York
$39.2M – – –
FIS
5
FCPM III Services
Netherlands
$30.8M – – –
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$27.7M +$16.1M +1,398,318 +1,252%
VPC
7
Vestal Point Capital
New York
$27.6M – – –
OM
8
Opaleye Management
Massachusetts
$24.1M +$1.54M +134,315 +11%
TCM
9
Tang Capital Management
California
$21.3M +$3.3M +287,602 +33%
VCM
10
Vanguard Capital Management
Pennsylvania
$14.7M +$9.2M +801,395 New
LGM
11
Logos Global Management
California
$8.86M -$1.35M -117,500 -20%
BCM
12
Boxer Capital Management
California
$8.33M – – –
DTC
13
Deep Track Capital
Connecticut
$8.33M – – –
NCM
14
NEXTBio Capital Management
California
$6.85M – – –
RI
15
RTW Investments
New York
$6.85M – – –
RCP
16
Remedium Capital Partners
Florida
$6.64M – – –
Millennium Management
17
Millennium Management
New York
$5.94M +$3M +261,671 +423%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$5.58M -$397K -34,574 -10%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$5.51M – – –
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$4.85M – – –
Goldman Sachs
21
Goldman Sachs
New York
$4.2M +$2.33M +203,230 +805%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$3.92M +$1.8M +156,587 +274%
PA
23
Perceptive Advisors
New York
$3.8M -$2.83M -246,744 -54%
Marshall Wace
24
Marshall Wace
United Kingdom
$3.69M +$2.05M +178,954 +820%
EAM
25
Exome Asset Management
New York
$2.81M +$1.76M +153,191 New
1
2 3